COVID-19 Impact on Global Oligonucleotide, Market Insights and Forecast to 2026
Oligonucleotide market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oligonucleotide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oligonucleotide market is segmented into
The Oligonucleotide market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oligonucleotide market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oligonucleotide Market Share Analysis
Oligonucleotide market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oligonucleotide business, the date to enter into the Oligonucleotide market, Oligonucleotide product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Oligonucleotide market is segmented into
- DNA
- RNA
- Gene Chip
- Electrophoresis
- Fluorescence In Situ Hybridization
The Oligonucleotide market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oligonucleotide market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oligonucleotide Market Share Analysis
Oligonucleotide market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oligonucleotide business, the date to enter into the Oligonucleotide market, Oligonucleotide product introduction, recent developments, etc.
The major vendors covered:
- Abbott Molecular
- PerkinElmer
- SciGene Corporation
- Roche NimbleGen
- CytoTest
1 STUDY COVERAGE
1.1 Oligonucleotide Product Introduction
1.2 Market Segments
1.3 Key Oligonucleotide Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oligonucleotide Market Size Growth Rate by Type
1.4.2 DNA
1.4.3 RNA
1.5 Market by Application
1.5.1 Global Oligonucleotide Market Size Growth Rate by Application
1.5.2 Gene Chip
1.5.3 Electrophoresis
1.5.4 Fluorescence In Situ Hybridization
1.6 Coronavirus Disease 2019 (Covid-19): Oligonucleotide Industry Impact
1.6.1 How the Covid-19 is Affecting the Oligonucleotide Industry
1.6.1.1 Oligonucleotide Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Oligonucleotide Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Oligonucleotide Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Oligonucleotide Market Size Estimates and Forecasts
2.1.1 Global Oligonucleotide Revenue 2015-2026
2.1.2 Global Oligonucleotide Sales 2015-2026
2.2 Oligonucleotide Market Size by Region: 2020 Versus 2026
2.2.1 Global Oligonucleotide Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oligonucleotide Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OLIGONUCLEOTIDE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Oligonucleotide Sales by Manufacturers
3.1.1 Oligonucleotide Sales by Manufacturers (2015-2020)
3.1.2 Oligonucleotide Sales Market Share by Manufacturers (2015-2020)
3.2 Oligonucleotide Revenue by Manufacturers
3.2.1 Oligonucleotide Revenue by Manufacturers (2015-2020)
3.2.2 Oligonucleotide Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oligonucleotide Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oligonucleotide Revenue in 2019
3.2.5 Global Oligonucleotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oligonucleotide Price by Manufacturers
3.4 Oligonucleotide Manufacturing Base Distribution, Product Types
3.4.1 Oligonucleotide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oligonucleotide Product Type
3.4.3 Date of International Manufacturers Enter into Oligonucleotide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Oligonucleotide Market Size by Type (2015-2020)
4.1.1 Global Oligonucleotide Sales by Type (2015-2020)
4.1.2 Global Oligonucleotide Revenue by Type (2015-2020)
4.1.3 Oligonucleotide Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oligonucleotide Market Size Forecast by Type (2021-2026)
4.2.1 Global Oligonucleotide Sales Forecast by Type (2021-2026)
4.2.2 Global Oligonucleotide Revenue Forecast by Type (2021-2026)
4.2.3 Oligonucleotide Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oligonucleotide Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Oligonucleotide Market Size by Application (2015-2020)
5.1.1 Global Oligonucleotide Sales by Application (2015-2020)
5.1.2 Global Oligonucleotide Revenue by Application (2015-2020)
5.1.3 Oligonucleotide Price by Application (2015-2020)
5.2 Oligonucleotide Market Size Forecast by Application (2021-2026)
5.2.1 Global Oligonucleotide Sales Forecast by Application (2021-2026)
5.2.2 Global Oligonucleotide Revenue Forecast by Application (2021-2026)
5.2.3 Global Oligonucleotide Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Oligonucleotide by Country
6.1.1 North America Oligonucleotide Sales by Country
6.1.2 North America Oligonucleotide Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oligonucleotide Market Facts & Figures by Type
6.3 North America Oligonucleotide Market Facts & Figures by Application
7 EUROPE
7.1 Europe Oligonucleotide by Country
7.1.1 Europe Oligonucleotide Sales by Country
7.1.2 Europe Oligonucleotide Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oligonucleotide Market Facts & Figures by Type
7.3 Europe Oligonucleotide Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Oligonucleotide by Region
8.1.1 Asia Pacific Oligonucleotide Sales by Region
8.1.2 Asia Pacific Oligonucleotide Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oligonucleotide Market Facts & Figures by Type
8.3 Asia Pacific Oligonucleotide Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Oligonucleotide by Country
9.1.1 Latin America Oligonucleotide Sales by Country
9.1.2 Latin America Oligonucleotide Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oligonucleotide Market Facts & Figures by Type
9.3 Central & South America Oligonucleotide Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Oligonucleotide by Country
10.1.1 Middle East and Africa Oligonucleotide Sales by Country
10.1.2 Middle East and Africa Oligonucleotide Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oligonucleotide Market Facts & Figures by Type
10.3 Middle East and Africa Oligonucleotide Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Abbott Molecular
11.1.1 Abbott Molecular Corporation Information
11.1.2 Abbott Molecular Description, Business Overview and Total Revenue
11.1.3 Abbott Molecular Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Molecular Oligonucleotide Products Offered
11.1.5 Abbott Molecular Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Corporation Information
11.2.2 PerkinElmer Description, Business Overview and Total Revenue
11.2.3 PerkinElmer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 PerkinElmer Oligonucleotide Products Offered
11.2.5 PerkinElmer Recent Development
11.3 SciGene Corporation
11.3.1 SciGene Corporation Corporation Information
11.3.2 SciGene Corporation Description, Business Overview and Total Revenue
11.3.3 SciGene Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 SciGene Corporation Oligonucleotide Products Offered
11.3.5 SciGene Corporation Recent Development
11.4 Roche NimbleGen
11.4.1 Roche NimbleGen Corporation Information
11.4.2 Roche NimbleGen Description, Business Overview and Total Revenue
11.4.3 Roche NimbleGen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Roche NimbleGen Oligonucleotide Products Offered
11.4.5 Roche NimbleGen Recent Development
11.5 CytoTest
11.5.1 CytoTest Corporation Information
11.5.2 CytoTest Description, Business Overview and Total Revenue
11.5.3 CytoTest Sales, Revenue and Gross Margin (2015-2020)
11.5.4 CytoTest Oligonucleotide Products Offered
11.5.5 CytoTest Recent Development
11.1 Abbott Molecular
11.1.1 Abbott Molecular Corporation Information
11.1.2 Abbott Molecular Description, Business Overview and Total Revenue
11.1.3 Abbott Molecular Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Molecular Oligonucleotide Products Offered
11.1.5 Abbott Molecular Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Oligonucleotide Market Estimates and Projections by Region
12.1.1 Global Oligonucleotide Sales Forecast by Regions 2021-2026
12.1.2 Global Oligonucleotide Revenue Forecast by Regions 2021-2026
12.2 North America Oligonucleotide Market Size Forecast (2021-2026)
12.2.1 North America: Oligonucleotide Sales Forecast (2021-2026)
12.2.2 North America: Oligonucleotide Revenue Forecast (2021-2026)
12.2.3 North America: Oligonucleotide Market Size Forecast by Country (2021-2026)
12.3 Europe Oligonucleotide Market Size Forecast (2021-2026)
12.3.1 Europe: Oligonucleotide Sales Forecast (2021-2026)
12.3.2 Europe: Oligonucleotide Revenue Forecast (2021-2026)
12.3.3 Europe: Oligonucleotide Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oligonucleotide Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oligonucleotide Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oligonucleotide Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oligonucleotide Market Size Forecast by Region (2021-2026)
12.5 Latin America Oligonucleotide Market Size Forecast (2021-2026)
12.5.1 Latin America: Oligonucleotide Sales Forecast (2021-2026)
12.5.2 Latin America: Oligonucleotide Revenue Forecast (2021-2026)
12.5.3 Latin America: Oligonucleotide Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oligonucleotide Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oligonucleotide Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oligonucleotide Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oligonucleotide Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oligonucleotide Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Oligonucleotide Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Oligonucleotide Product Introduction
1.2 Market Segments
1.3 Key Oligonucleotide Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oligonucleotide Market Size Growth Rate by Type
1.4.2 DNA
1.4.3 RNA
1.5 Market by Application
1.5.1 Global Oligonucleotide Market Size Growth Rate by Application
1.5.2 Gene Chip
1.5.3 Electrophoresis
1.5.4 Fluorescence In Situ Hybridization
1.6 Coronavirus Disease 2019 (Covid-19): Oligonucleotide Industry Impact
1.6.1 How the Covid-19 is Affecting the Oligonucleotide Industry
1.6.1.1 Oligonucleotide Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Oligonucleotide Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Oligonucleotide Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Oligonucleotide Market Size Estimates and Forecasts
2.1.1 Global Oligonucleotide Revenue 2015-2026
2.1.2 Global Oligonucleotide Sales 2015-2026
2.2 Oligonucleotide Market Size by Region: 2020 Versus 2026
2.2.1 Global Oligonucleotide Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oligonucleotide Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OLIGONUCLEOTIDE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Oligonucleotide Sales by Manufacturers
3.1.1 Oligonucleotide Sales by Manufacturers (2015-2020)
3.1.2 Oligonucleotide Sales Market Share by Manufacturers (2015-2020)
3.2 Oligonucleotide Revenue by Manufacturers
3.2.1 Oligonucleotide Revenue by Manufacturers (2015-2020)
3.2.2 Oligonucleotide Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oligonucleotide Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oligonucleotide Revenue in 2019
3.2.5 Global Oligonucleotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oligonucleotide Price by Manufacturers
3.4 Oligonucleotide Manufacturing Base Distribution, Product Types
3.4.1 Oligonucleotide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oligonucleotide Product Type
3.4.3 Date of International Manufacturers Enter into Oligonucleotide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Oligonucleotide Market Size by Type (2015-2020)
4.1.1 Global Oligonucleotide Sales by Type (2015-2020)
4.1.2 Global Oligonucleotide Revenue by Type (2015-2020)
4.1.3 Oligonucleotide Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oligonucleotide Market Size Forecast by Type (2021-2026)
4.2.1 Global Oligonucleotide Sales Forecast by Type (2021-2026)
4.2.2 Global Oligonucleotide Revenue Forecast by Type (2021-2026)
4.2.3 Oligonucleotide Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oligonucleotide Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Oligonucleotide Market Size by Application (2015-2020)
5.1.1 Global Oligonucleotide Sales by Application (2015-2020)
5.1.2 Global Oligonucleotide Revenue by Application (2015-2020)
5.1.3 Oligonucleotide Price by Application (2015-2020)
5.2 Oligonucleotide Market Size Forecast by Application (2021-2026)
5.2.1 Global Oligonucleotide Sales Forecast by Application (2021-2026)
5.2.2 Global Oligonucleotide Revenue Forecast by Application (2021-2026)
5.2.3 Global Oligonucleotide Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Oligonucleotide by Country
6.1.1 North America Oligonucleotide Sales by Country
6.1.2 North America Oligonucleotide Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oligonucleotide Market Facts & Figures by Type
6.3 North America Oligonucleotide Market Facts & Figures by Application
7 EUROPE
7.1 Europe Oligonucleotide by Country
7.1.1 Europe Oligonucleotide Sales by Country
7.1.2 Europe Oligonucleotide Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oligonucleotide Market Facts & Figures by Type
7.3 Europe Oligonucleotide Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Oligonucleotide by Region
8.1.1 Asia Pacific Oligonucleotide Sales by Region
8.1.2 Asia Pacific Oligonucleotide Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oligonucleotide Market Facts & Figures by Type
8.3 Asia Pacific Oligonucleotide Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Oligonucleotide by Country
9.1.1 Latin America Oligonucleotide Sales by Country
9.1.2 Latin America Oligonucleotide Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oligonucleotide Market Facts & Figures by Type
9.3 Central & South America Oligonucleotide Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Oligonucleotide by Country
10.1.1 Middle East and Africa Oligonucleotide Sales by Country
10.1.2 Middle East and Africa Oligonucleotide Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oligonucleotide Market Facts & Figures by Type
10.3 Middle East and Africa Oligonucleotide Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Abbott Molecular
11.1.1 Abbott Molecular Corporation Information
11.1.2 Abbott Molecular Description, Business Overview and Total Revenue
11.1.3 Abbott Molecular Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Molecular Oligonucleotide Products Offered
11.1.5 Abbott Molecular Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Corporation Information
11.2.2 PerkinElmer Description, Business Overview and Total Revenue
11.2.3 PerkinElmer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 PerkinElmer Oligonucleotide Products Offered
11.2.5 PerkinElmer Recent Development
11.3 SciGene Corporation
11.3.1 SciGene Corporation Corporation Information
11.3.2 SciGene Corporation Description, Business Overview and Total Revenue
11.3.3 SciGene Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 SciGene Corporation Oligonucleotide Products Offered
11.3.5 SciGene Corporation Recent Development
11.4 Roche NimbleGen
11.4.1 Roche NimbleGen Corporation Information
11.4.2 Roche NimbleGen Description, Business Overview and Total Revenue
11.4.3 Roche NimbleGen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Roche NimbleGen Oligonucleotide Products Offered
11.4.5 Roche NimbleGen Recent Development
11.5 CytoTest
11.5.1 CytoTest Corporation Information
11.5.2 CytoTest Description, Business Overview and Total Revenue
11.5.3 CytoTest Sales, Revenue and Gross Margin (2015-2020)
11.5.4 CytoTest Oligonucleotide Products Offered
11.5.5 CytoTest Recent Development
11.1 Abbott Molecular
11.1.1 Abbott Molecular Corporation Information
11.1.2 Abbott Molecular Description, Business Overview and Total Revenue
11.1.3 Abbott Molecular Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Molecular Oligonucleotide Products Offered
11.1.5 Abbott Molecular Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Oligonucleotide Market Estimates and Projections by Region
12.1.1 Global Oligonucleotide Sales Forecast by Regions 2021-2026
12.1.2 Global Oligonucleotide Revenue Forecast by Regions 2021-2026
12.2 North America Oligonucleotide Market Size Forecast (2021-2026)
12.2.1 North America: Oligonucleotide Sales Forecast (2021-2026)
12.2.2 North America: Oligonucleotide Revenue Forecast (2021-2026)
12.2.3 North America: Oligonucleotide Market Size Forecast by Country (2021-2026)
12.3 Europe Oligonucleotide Market Size Forecast (2021-2026)
12.3.1 Europe: Oligonucleotide Sales Forecast (2021-2026)
12.3.2 Europe: Oligonucleotide Revenue Forecast (2021-2026)
12.3.3 Europe: Oligonucleotide Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oligonucleotide Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oligonucleotide Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oligonucleotide Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oligonucleotide Market Size Forecast by Region (2021-2026)
12.5 Latin America Oligonucleotide Market Size Forecast (2021-2026)
12.5.1 Latin America: Oligonucleotide Sales Forecast (2021-2026)
12.5.2 Latin America: Oligonucleotide Revenue Forecast (2021-2026)
12.5.3 Latin America: Oligonucleotide Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oligonucleotide Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oligonucleotide Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oligonucleotide Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oligonucleotide Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oligonucleotide Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Oligonucleotide Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Oligonucleotide Market Segments
Table 2. Ranking of Global Top Oligonucleotide Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oligonucleotide Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of DNA
Table 5. Major Manufacturers of RNA
Table 6. COVID-19 Impact Global Market: (Four Oligonucleotide Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Oligonucleotide Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Oligonucleotide Players to Combat Covid-19 Impact
Table 11. Global Oligonucleotide Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Oligonucleotide Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Oligonucleotide Sales by Regions 2015-2020 (K MT)
Table 14. Global Oligonucleotide Sales Market Share by Regions (2015-2020)
Table 15. Global Oligonucleotide Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Oligonucleotide Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Oligonucleotide Sales Share by Manufacturers (2015-2020)
Table 18. Global Oligonucleotide Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Oligonucleotide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide as of 2019)
Table 20. Oligonucleotide Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Oligonucleotide Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Oligonucleotide Price (2015-2020) (USD/MT)
Table 23. Oligonucleotide Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Oligonucleotide Product Type
Table 25. Date of International Manufacturers Enter into Oligonucleotide Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Oligonucleotide Sales by Type (2015-2020) (K MT)
Table 28. Global Oligonucleotide Sales Share by Type (2015-2020)
Table 29. Global Oligonucleotide Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Oligonucleotide Revenue Share by Type (2015-2020)
Table 31. Oligonucleotide Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Oligonucleotide Sales by Application (2015-2020) (K MT)
Table 33. Global Oligonucleotide Sales Share by Application (2015-2020)
Table 34. North America Oligonucleotide Sales by Country (2015-2020) (K MT)
Table 35. North America Oligonucleotide Sales Market Share by Country (2015-2020)
Table 36. North America Oligonucleotide Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Oligonucleotide Revenue Market Share by Country (2015-2020)
Table 38. North America Oligonucleotide Sales by Type (2015-2020) (K MT)
Table 39. North America Oligonucleotide Sales Market Share by Type (2015-2020)
Table 40. North America Oligonucleotide Sales by Application (2015-2020) (K MT)
Table 41. North America Oligonucleotide Sales Market Share by Application (2015-2020)
Table 42. Europe Oligonucleotide Sales by Country (2015-2020) (K MT)
Table 43. Europe Oligonucleotide Sales Market Share by Country (2015-2020)
Table 44. Europe Oligonucleotide Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Oligonucleotide Revenue Market Share by Country (2015-2020)
Table 46. Europe Oligonucleotide Sales by Type (2015-2020) (K MT)
Table 47. Europe Oligonucleotide Sales Market Share by Type (2015-2020)
Table 48. Europe Oligonucleotide Sales by Application (2015-2020) (K MT)
Table 49. Europe Oligonucleotide Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Oligonucleotide Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Oligonucleotide Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Oligonucleotide Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Oligonucleotide Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Oligonucleotide Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Oligonucleotide Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Oligonucleotide Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Oligonucleotide Sales Market Share by Application (2015-2020)
Table 58. Latin America Oligonucleotide Sales by Country (2015-2020) (K MT)
Table 59. Latin America Oligonucleotide Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Oligonucleotide Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Oligonucleotide Revenue Market Share by Country (2015-2020)
Table 62. Latin America Oligonucleotide Sales by Type (2015-2020) (K MT)
Table 63. Latin America Oligonucleotide Sales Market Share by Type (2015-2020)
Table 64. Latin America Oligonucleotide Sales by Application (2015-2020) (K MT)
Table 65. Latin America Oligonucleotide Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Oligonucleotide Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Oligonucleotide Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Oligonucleotide Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Oligonucleotide Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Oligonucleotide Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Oligonucleotide Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Oligonucleotide Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Oligonucleotide Sales Market Share by Application (2015-2020)
Table 74. Abbott Molecular Corporation Information
Table 75. Abbott Molecular Description and Major Businesses
Table 76. Abbott Molecular Oligonucleotide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Abbott Molecular Product
Table 78. Abbott Molecular Recent Development
Table 79. PerkinElmer Corporation Information
Table 80. PerkinElmer Description and Major Businesses
Table 81. PerkinElmer Oligonucleotide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. PerkinElmer Product
Table 83. PerkinElmer Recent Development
Table 84. SciGene Corporation Corporation Information
Table 85. SciGene Corporation Description and Major Businesses
Table 86. SciGene Corporation Oligonucleotide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. SciGene Corporation Product
Table 88. SciGene Corporation Recent Development
Table 89. Roche NimbleGen Corporation Information
Table 90. Roche NimbleGen Description and Major Businesses
Table 91. Roche NimbleGen Oligonucleotide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Roche NimbleGen Product
Table 93. Roche NimbleGen Recent Development
Table 94. CytoTest Corporation Information
Table 95. CytoTest Description and Major Businesses
Table 96. CytoTest Oligonucleotide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. CytoTest Product
Table 98. CytoTest Recent Development
Table 99. Global Oligonucleotide Sales Forecast by Regions (2021-2026) (K MT)
Table 100. Global Oligonucleotide Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Oligonucleotide Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Oligonucleotide Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Oligonucleotide Sales Forecast by Country (2021-2026) (K MT)
Table 104. North America: Oligonucleotide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Oligonucleotide Sales Forecast by Country (2021-2026) (K MT)
Table 106. Europe: Oligonucleotide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Oligonucleotide Sales Forecast by Region (2021-2026) (K MT)
Table 108. Asia Pacific: Oligonucleotide Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Oligonucleotide Sales Forecast by Country (2021-2026) (K MT)
Table 110. Latin America: Oligonucleotide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Oligonucleotide Sales Forecast by Country (2021-2026) (K MT)
Table 112. Middle East and Africa: Oligonucleotide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Oligonucleotide Players
Table 117. Oligonucleotide Customers List
Table 118. Oligonucleotide Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 1. Oligonucleotide Market Segments
Table 2. Ranking of Global Top Oligonucleotide Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oligonucleotide Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of DNA
Table 5. Major Manufacturers of RNA
Table 6. COVID-19 Impact Global Market: (Four Oligonucleotide Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Oligonucleotide Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Oligonucleotide Players to Combat Covid-19 Impact
Table 11. Global Oligonucleotide Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Oligonucleotide Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Oligonucleotide Sales by Regions 2015-2020 (K MT)
Table 14. Global Oligonucleotide Sales Market Share by Regions (2015-2020)
Table 15. Global Oligonucleotide Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Oligonucleotide Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Oligonucleotide Sales Share by Manufacturers (2015-2020)
Table 18. Global Oligonucleotide Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Oligonucleotide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide as of 2019)
Table 20. Oligonucleotide Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Oligonucleotide Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Oligonucleotide Price (2015-2020) (USD/MT)
Table 23. Oligonucleotide Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Oligonucleotide Product Type
Table 25. Date of International Manufacturers Enter into Oligonucleotide Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Oligonucleotide Sales by Type (2015-2020) (K MT)
Table 28. Global Oligonucleotide Sales Share by Type (2015-2020)
Table 29. Global Oligonucleotide Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Oligonucleotide Revenue Share by Type (2015-2020)
Table 31. Oligonucleotide Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Oligonucleotide Sales by Application (2015-2020) (K MT)
Table 33. Global Oligonucleotide Sales Share by Application (2015-2020)
Table 34. North America Oligonucleotide Sales by Country (2015-2020) (K MT)
Table 35. North America Oligonucleotide Sales Market Share by Country (2015-2020)
Table 36. North America Oligonucleotide Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Oligonucleotide Revenue Market Share by Country (2015-2020)
Table 38. North America Oligonucleotide Sales by Type (2015-2020) (K MT)
Table 39. North America Oligonucleotide Sales Market Share by Type (2015-2020)
Table 40. North America Oligonucleotide Sales by Application (2015-2020) (K MT)
Table 41. North America Oligonucleotide Sales Market Share by Application (2015-2020)
Table 42. Europe Oligonucleotide Sales by Country (2015-2020) (K MT)
Table 43. Europe Oligonucleotide Sales Market Share by Country (2015-2020)
Table 44. Europe Oligonucleotide Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Oligonucleotide Revenue Market Share by Country (2015-2020)
Table 46. Europe Oligonucleotide Sales by Type (2015-2020) (K MT)
Table 47. Europe Oligonucleotide Sales Market Share by Type (2015-2020)
Table 48. Europe Oligonucleotide Sales by Application (2015-2020) (K MT)
Table 49. Europe Oligonucleotide Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Oligonucleotide Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Oligonucleotide Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Oligonucleotide Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Oligonucleotide Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Oligonucleotide Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Oligonucleotide Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Oligonucleotide Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Oligonucleotide Sales Market Share by Application (2015-2020)
Table 58. Latin America Oligonucleotide Sales by Country (2015-2020) (K MT)
Table 59. Latin America Oligonucleotide Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Oligonucleotide Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Oligonucleotide Revenue Market Share by Country (2015-2020)
Table 62. Latin America Oligonucleotide Sales by Type (2015-2020) (K MT)
Table 63. Latin America Oligonucleotide Sales Market Share by Type (2015-2020)
Table 64. Latin America Oligonucleotide Sales by Application (2015-2020) (K MT)
Table 65. Latin America Oligonucleotide Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Oligonucleotide Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Oligonucleotide Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Oligonucleotide Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Oligonucleotide Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Oligonucleotide Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Oligonucleotide Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Oligonucleotide Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Oligonucleotide Sales Market Share by Application (2015-2020)
Table 74. Abbott Molecular Corporation Information
Table 75. Abbott Molecular Description and Major Businesses
Table 76. Abbott Molecular Oligonucleotide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Abbott Molecular Product
Table 78. Abbott Molecular Recent Development
Table 79. PerkinElmer Corporation Information
Table 80. PerkinElmer Description and Major Businesses
Table 81. PerkinElmer Oligonucleotide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. PerkinElmer Product
Table 83. PerkinElmer Recent Development
Table 84. SciGene Corporation Corporation Information
Table 85. SciGene Corporation Description and Major Businesses
Table 86. SciGene Corporation Oligonucleotide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. SciGene Corporation Product
Table 88. SciGene Corporation Recent Development
Table 89. Roche NimbleGen Corporation Information
Table 90. Roche NimbleGen Description and Major Businesses
Table 91. Roche NimbleGen Oligonucleotide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Roche NimbleGen Product
Table 93. Roche NimbleGen Recent Development
Table 94. CytoTest Corporation Information
Table 95. CytoTest Description and Major Businesses
Table 96. CytoTest Oligonucleotide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. CytoTest Product
Table 98. CytoTest Recent Development
Table 99. Global Oligonucleotide Sales Forecast by Regions (2021-2026) (K MT)
Table 100. Global Oligonucleotide Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Oligonucleotide Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Oligonucleotide Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Oligonucleotide Sales Forecast by Country (2021-2026) (K MT)
Table 104. North America: Oligonucleotide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Oligonucleotide Sales Forecast by Country (2021-2026) (K MT)
Table 106. Europe: Oligonucleotide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Oligonucleotide Sales Forecast by Region (2021-2026) (K MT)
Table 108. Asia Pacific: Oligonucleotide Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Oligonucleotide Sales Forecast by Country (2021-2026) (K MT)
Table 110. Latin America: Oligonucleotide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Oligonucleotide Sales Forecast by Country (2021-2026) (K MT)
Table 112. Middle East and Africa: Oligonucleotide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Oligonucleotide Players
Table 117. Oligonucleotide Customers List
Table 118. Oligonucleotide Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Oligonucleotide Product Picture
Figure 2. Global Oligonucleotide Sales Market Share by Type in 2020 & 2026
Figure 3. DNA Product Picture
Figure 4. RNA Product Picture
Figure 5. Global Oligonucleotide Sales Market Share by Application in 2020 & 2026
Figure 6. Gene Chip
Figure 7. Electrophoresis
Figure 8. Fluorescence In Situ Hybridization
Figure 9. Oligonucleotide Report Years Considered
Figure 10. Global Oligonucleotide Market Size 2015-2026 (US$ Million)
Figure 11. Global Oligonucleotide Sales 2015-2026 (K MT)
Figure 12. Global Oligonucleotide Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Oligonucleotide Sales Market Share by Region (2015-2020)
Figure 14. Global Oligonucleotide Sales Market Share by Region in 2019
Figure 15. Global Oligonucleotide Revenue Market Share by Region (2015-2020)
Figure 16. Global Oligonucleotide Revenue Market Share by Region in 2019
Figure 17. Global Oligonucleotide Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Oligonucleotide Revenue in 2019
Figure 19. Oligonucleotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Oligonucleotide Sales Market Share by Type (2015-2020)
Figure 21. Global Oligonucleotide Sales Market Share by Type in 2019
Figure 22. Global Oligonucleotide Revenue Market Share by Type (2015-2020)
Figure 23. Global Oligonucleotide Revenue Market Share by Type in 2019
Figure 24. Global Oligonucleotide Market Share by Price Range (2015-2020)
Figure 25. Global Oligonucleotide Sales Market Share by Application (2015-2020)
Figure 26. Global Oligonucleotide Sales Market Share by Application in 2019
Figure 27. Global Oligonucleotide Revenue Market Share by Application (2015-2020)
Figure 28. Global Oligonucleotide Revenue Market Share by Application in 2019
Figure 29. North America Oligonucleotide Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Oligonucleotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Oligonucleotide Sales Market Share by Country in 2019
Figure 32. North America Oligonucleotide Revenue Market Share by Country in 2019
Figure 33. U.S. Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Oligonucleotide Market Share by Type in 2019
Figure 38. North America Oligonucleotide Market Share by Application in 2019
Figure 39. Europe Oligonucleotide Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Oligonucleotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Oligonucleotide Sales Market Share by Country in 2019
Figure 42. Europe Oligonucleotide Revenue Market Share by Country in 2019
Figure 43. Germany Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Oligonucleotide Market Share by Type in 2019
Figure 54. Europe Oligonucleotide Market Share by Application in 2019
Figure 55. Asia Pacific Oligonucleotide Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Oligonucleotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Oligonucleotide Sales Market Share by Region in 2019
Figure 58. Asia Pacific Oligonucleotide Revenue Market Share by Region in 2019
Figure 59. China Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Oligonucleotide Market Share by Type in 2019
Figure 82. Asia Pacific Oligonucleotide Market Share by Application in 2019
Figure 83. Latin America Oligonucleotide Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Oligonucleotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Oligonucleotide Sales Market Share by Country in 2019
Figure 86. Latin America Oligonucleotide Revenue Market Share by Country in 2019
Figure 87. Mexico Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Oligonucleotide Market Share by Type in 2019
Figure 94. Latin America Oligonucleotide Market Share by Application in 2019
Figure 95. Middle East and Africa Oligonucleotide Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Oligonucleotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Oligonucleotide Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Oligonucleotide Revenue Market Share by Country in 2019
Figure 99. Turkey Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Oligonucleotide Market Share by Type in 2019
Figure 106. Middle East and Africa Oligonucleotide Market Share by Application in 2019
Figure 107. Abbott Molecular Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. PerkinElmer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. SciGene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Roche NimbleGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. CytoTest Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. North America Oligonucleotide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. North America Oligonucleotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Oligonucleotide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Europe Oligonucleotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Oligonucleotide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Asia Pacific Oligonucleotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Oligonucleotide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Latin America Oligonucleotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Oligonucleotide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Middle East and Africa Oligonucleotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
Figure 1. Oligonucleotide Product Picture
Figure 2. Global Oligonucleotide Sales Market Share by Type in 2020 & 2026
Figure 3. DNA Product Picture
Figure 4. RNA Product Picture
Figure 5. Global Oligonucleotide Sales Market Share by Application in 2020 & 2026
Figure 6. Gene Chip
Figure 7. Electrophoresis
Figure 8. Fluorescence In Situ Hybridization
Figure 9. Oligonucleotide Report Years Considered
Figure 10. Global Oligonucleotide Market Size 2015-2026 (US$ Million)
Figure 11. Global Oligonucleotide Sales 2015-2026 (K MT)
Figure 12. Global Oligonucleotide Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Oligonucleotide Sales Market Share by Region (2015-2020)
Figure 14. Global Oligonucleotide Sales Market Share by Region in 2019
Figure 15. Global Oligonucleotide Revenue Market Share by Region (2015-2020)
Figure 16. Global Oligonucleotide Revenue Market Share by Region in 2019
Figure 17. Global Oligonucleotide Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Oligonucleotide Revenue in 2019
Figure 19. Oligonucleotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Oligonucleotide Sales Market Share by Type (2015-2020)
Figure 21. Global Oligonucleotide Sales Market Share by Type in 2019
Figure 22. Global Oligonucleotide Revenue Market Share by Type (2015-2020)
Figure 23. Global Oligonucleotide Revenue Market Share by Type in 2019
Figure 24. Global Oligonucleotide Market Share by Price Range (2015-2020)
Figure 25. Global Oligonucleotide Sales Market Share by Application (2015-2020)
Figure 26. Global Oligonucleotide Sales Market Share by Application in 2019
Figure 27. Global Oligonucleotide Revenue Market Share by Application (2015-2020)
Figure 28. Global Oligonucleotide Revenue Market Share by Application in 2019
Figure 29. North America Oligonucleotide Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Oligonucleotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Oligonucleotide Sales Market Share by Country in 2019
Figure 32. North America Oligonucleotide Revenue Market Share by Country in 2019
Figure 33. U.S. Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Oligonucleotide Market Share by Type in 2019
Figure 38. North America Oligonucleotide Market Share by Application in 2019
Figure 39. Europe Oligonucleotide Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Oligonucleotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Oligonucleotide Sales Market Share by Country in 2019
Figure 42. Europe Oligonucleotide Revenue Market Share by Country in 2019
Figure 43. Germany Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Oligonucleotide Market Share by Type in 2019
Figure 54. Europe Oligonucleotide Market Share by Application in 2019
Figure 55. Asia Pacific Oligonucleotide Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Oligonucleotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Oligonucleotide Sales Market Share by Region in 2019
Figure 58. Asia Pacific Oligonucleotide Revenue Market Share by Region in 2019
Figure 59. China Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Oligonucleotide Market Share by Type in 2019
Figure 82. Asia Pacific Oligonucleotide Market Share by Application in 2019
Figure 83. Latin America Oligonucleotide Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Oligonucleotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Oligonucleotide Sales Market Share by Country in 2019
Figure 86. Latin America Oligonucleotide Revenue Market Share by Country in 2019
Figure 87. Mexico Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Oligonucleotide Market Share by Type in 2019
Figure 94. Latin America Oligonucleotide Market Share by Application in 2019
Figure 95. Middle East and Africa Oligonucleotide Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Oligonucleotide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Oligonucleotide Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Oligonucleotide Revenue Market Share by Country in 2019
Figure 99. Turkey Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Oligonucleotide Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Oligonucleotide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Oligonucleotide Market Share by Type in 2019
Figure 106. Middle East and Africa Oligonucleotide Market Share by Application in 2019
Figure 107. Abbott Molecular Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. PerkinElmer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. SciGene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Roche NimbleGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. CytoTest Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. North America Oligonucleotide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. North America Oligonucleotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Oligonucleotide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Europe Oligonucleotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Oligonucleotide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Asia Pacific Oligonucleotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Oligonucleotide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Latin America Oligonucleotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Oligonucleotide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Middle East and Africa Oligonucleotide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
